ZLZheng Li

Zheng Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zheng Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Apocynum venetum leaf extract protects against H2O2-induced oxidative stress by increasing autophagy in PC12 cells

    by Yuelai Feng, Chang Jiang, Feng Yang, Zixian Chen, Zheng Li

    The effect of generated.Italic@104c035a leaf extract (AVLE) on the nervous system has been widely studied, but its effect on injured neurons is not fully understood. In the present study, the protective effect of AVLE on injured neurons was determined. H2O2 was used to induce oxidative stress in PC12 cells and cell viability assays were used to determine the optimum concentration range of AVLE and its protective effects against oxidative stress. A live-dead assay was performed to confirm the effects of AVLE on oxidative stress. Subsequently, expression of apoptotic proteins including Bax and cleaved-caspase-3 were evaluated to determine whether AVLE affected apoptosis, and reactive oxygen species (ROS) levels were detected to determine the role of AVLE in H2O2 exposure. Furthermore, expression of autophagic proteins including LC3-II and p62 were detected to evaluate the effects of AVLE on autophagic activity, and cells were treated with 3-methyladenine (3-MA), an autophagic inhibitor, to identify the underlying protective mechanism of AVLE. The results showed that the optimum conditions to induce oxidative stress were treatment with 40 µM H2O2 for 2 h, and the suitable range of AVLE concentrations was shown to be 1-100 µg/ml. AVLE improved cell viability in PC12 cells following treatment with H2O2. AVLE reduced the expression of Bax and cleaved-caspase-3, and decreased ROS production. Furthermore, AVLE upregulated LC3-II expression and downregulated p62 expression, whereas treatment with 3-MA increased the levels of ROS and apoptotic proteins. These results suggest that AVLE may protect injured neurons against oxidative stress-induced apoptosis, and this effect may be associated with the reduction of ROS by increasing autophagy.


  • Open Access

    Urolithin a attenuates IL-1β-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-κB signaling pathways in rat articular chondrocytes

    by Sheng-Long Ding, Zhi-Ying Pang, Xue-Mei Chen, Zheng Li, Xin-Xin Liu, Qi-Lin Zhai, Jun-Ming Huang, Zhi-Yong Ruan

    Background: Osteoarthritis (OA) is characterized by inflammation and extracellular matrix (ECM) degradation and is one of the most common chronic degenerative joint diseases that causes pain and disability in adults. Urolithin A (UA) has been widely reported for its anti-inflammatory properties in several chronic diseases. However, the effects of UA on OA remain unclear. The aim of the current study was to investigate the anti-inflammatory effects and mechanism of UA in interleukin-1β (IL-1β)-induced chondrocytes. Results: No marked UA cytotoxicity was noted, and UA protected cartilage from damage following IL-1β stimulation in micromasses. Moreover, UA promoted the expression of anabolic factors including Sox-9, Collagen II, and Aggrecan while inhibiting the expression of catabolic factors such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) in rat chondrocytes. Protective effects of UA were also observed in ex vivo organ culture of articular cartilage. Mechanistically, IL-1β significantly activated and upregulated the expression of p-ERK 1/2, p-JNK, p-P38, and p-P65, while UA protected chondrocytes against IL-1β-induced injury by activating the mitogen-activated kinase (MAPK)/nuclear factor-κB (NF-κB) signaling pathways. Conclusion: Our results provide the evidence that UA could attenuate IL-1β-induced cell injury in chondrocytes via its anti-inflammatory action. UA may be a promising therapeutic agent in the treatment of OA.